Largest pharmaceutical companies in the United States by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 44 pharmaceutical companies in the United States ranked by total assets, at THB 7.05T, ahead of Johnson & Johnson (THB 6.75T) and Merck & Co (THB 4.64T). Figures as of 20 Nov 2026, 11:15 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- PfizerTHB 7.05T
- Median
- THB 50.6B
- Combined market value
- THB 126.61T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | THB 7.05T | THB 5.32T | THB 933.33 | 1.85% down | 15% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | THB 6.75T | THB 21.79T | THB 9,053.37 | 2.04% down | 34% up | ||
| 3 | Merck & CoMRK · Health Care | THB 4.64T | THB 11.1T | THB 4,500.93 | 3.61% down | 45% up | ||
| 4 | AbbVieABBV · Health Care | THB 4.54T | THB 16.99T | THB 9,609.17 | 0.86% down | 25% up | ||
| 5 | Eli LillyLLY · Health Care | THB 3.81T | THB 40.79T | THB 45,789.46 | 2.29% down | 33% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | THB 3.05T | THB 4.04T | THB 1,977.14 | 2.05% down | 30% up | ||
| 7 | Abbott LaboratoriesABT · Health Care | THB 2.94T | THB 6.1T | THB 3,520.15 | 0.58% down | 16% down | ||
| 8 | Regeneron PharmaceuticalsREGN · Health Care | THB 1.37T | THB 3.24T | THB 31,291.99 | 2.35% down | 28% up | ||
| 9 | ViatrisVTRS · Health Care | THB 1.26T | THB 772.4B | THB 673.73 | 1.97% down | 99% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | THB 869B | THB 4.47T | THB 17,645.17 | 2.94% down | 27% up | ||
| 11 | Royalty PharmaRPRX · Health Care | THB 664.9B | THB 1.32T | THB 2,295.03 | 1.38% down | 79% up | ||
| 12 | ZoetisZTS · Health Care | THB 524.2B | THB 1.11T | THB 2,737.97 | 5.59% down | 26% down | ||
| 13 | Elanco Animal HealthELAN · Health Care | THB 452.7B | THB 445.3B | THB 890.97 | 1.54% down | 26% up | ||
| 14 | United TherapeuticsUTHR · Health Care | THB 267.1B | THB 807B | THB 18,947.90 | 3.16% down | 22% up | ||
| 15 | BioMarin PharmaceuticalBMRN · Health Care | THB 257.4B | THB 403.2B | THB 2,081.52 | 0.02% down | 17% up | ||
| 16 | Alnylam PharmaceuticalsALNY · Health Care | THB 168.3B | THB 671B | THB 5,009.62 | 1.06% down | 66% down | ||
| 17 | Amneal PharmaceuticalsAMRX · Health Care | THB 124.7B | THB 252.6B | THB 724.91 | 2.24% down | 90% up | ||
| 18 | Ionis PharmaceuticalsIONS · Health Care | THB 119.4B | THB 153.6B | THB 922.49 | 0.62% down | 63% down | ||
| 19 | PTC TherapeuticsPTCT · Health Care | THB 98.2B | THB 165.1B | THB 1,976.63 | 3.16% down | 21% down | ||
| 20 | InsmedINSM · Health Care | THB 76.7B | THB 1.07T | THB 4,895.75 | 20.58% up | 40% down | ||
| 21 | Legend BiotechLEGN · Health Care | THB 58.8B | THB 105.8B | THB 545.63 | 0.92% down | 41% down | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | THB 52.9B | THB 194.5B | THB 9,724.40 | 3.94% down | 50% up | ||
| 23 | CytokineticsCYTK · Health Care | THB 48.3B | THB 242.9B | THB 1,743.98 | 0.27% up | 19% down | ||
| 24 | Arrowhead PharmaceuticalsARWR · Health Care | THB 46.9B | THB 209.1B | THB 1,479.30 | 1.25% up | 13% up | ||
| 25 | Madrigal PharmaceuticalsMDGL · Health Care | THB 42.7B | THB 312.3B | THB 13,445.52 | 0.34% down | 27% down | ||
| 26 | TG TherapeuticsTGTX · Health Care | THB 36B | THB 332.3B | THB 2,198.78 | 1.88% down | 117% up | ||
| 27 | Praxis Precision MedicinesPRAX · Health Care | THB 31.8B | THB 294.5B | THB 10,536.40 | 1.87% up | 86% up | ||
| 28 | Cogent BiosciencesCOGT · Health Care | THB 31.8B | THB 163.6B | THB 940.11 | 0.25% down | 20% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | THB 31.7B | THB 516.1B | THB 2,649.52 | 0.22% up | 21% up | ||
| 30 | Mirum PharmaceuticalsMIRM · Health Care | THB 28.6B | THB 211.3B | THB 3,236.83 | 3.27% up | 34% up | ||
| 31 | Corcept TherapeuticsCORT · Health Care | THB 28.4B | THB 241B | THB 2,202.17 | 4.15% down | 10% down | ||
| 32 | Belite BioBLTE · Health Care | THB 26.5B | THB 207.9B | THB 5,118.07 | 3.33% down | 43% up | ||
| 33 | Spyre TherapeuticsSYRE · Health Care | THB 26.4B | THB 314.2B | THB 3,308.68 | 3.77% down | 332% up | ||
| 34 | Summit TherapeuticsSMMT · Health Care | THB 25.5B | THB 286.5B | THB 358.22 | 0.67% up | 36% down | ||
| 35 | Axsome TherapeuticsAXSM · Health Care | THB 23.4B | THB 241.9B | THB 4,598.20 | 1.25% up | 6% down | ||
| 36 | Protagonist TherapeuticsPTGX · Health Care | THB 22.6B | THB 274.3B | THB 4,203.04 | 2.47% down | 51% up | ||
| 37 | Travere TherapeuticsTVTX · Health Care | THB 20.5B | THB 157.1B | THB 1,636.89 | 3.86% down | 45% up | ||
| 38 | Edgewise TherapeuticsEWTX · Health Care | THB 18.7B | THB 152.8B | THB 1,395.25 | 0.48% down | 86% up | ||
| 39 | Dianthus TherapeuticsDNTH · Health Care | THB 18B | THB 161.9B | THB 2,874.89 | 1.01% up | 108% up | ||
| 40 | Oruka TherapeuticsORKA · Health Care | THB 16.6B | THB 224.3B | THB 3,306.65 | 1.91% up | 255% up | ||
| 41 | Rhythm PharmaceuticalsRYTM · Health Care | THB 16.3B | THB 274.4B | THB 3,958.35 | 1.88% down | 18% up | ||
| 42 | Definium TherapeuticsDFTX · Health Care | THB 14.9B | THB 136.8B | THB 999.08 | 1.24% up | 168% up | ||
| 43 | ErascaERAS · Health Care | THB 13.4B | THB 169.1B | THB 481.92 | 3.34% up | 395% up | ||
| 44 | VeradermicsMANE · Health Care | THB 5.2B | THB 177.9B | THB 4,215.58 | 0.38% down | 231% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 33.8900 THB).
Questions and answers
Which pharmaceutical companies in the United States rank first by total assets?
Pfizer (THB 7.05T), Johnson & Johnson (THB 6.75T) and Merck & Co (THB 4.64T) are the top three of the 44 pharmaceutical companies in the United States ranked by total assets as of 20 Nov 2026, 11:15 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by total assets.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by total assets have a combined market value of THB 126.61T as of 20 Nov 2026, 11:15 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by total assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.